首页> 外国专利> Compositions comprising ZD6126 together with 5-FU, CPT-11 or 5-FU and CPT-11 having vascular damaging activity for treating e.g. colorectal cancer

Compositions comprising ZD6126 together with 5-FU, CPT-11 or 5-FU and CPT-11 having vascular damaging activity for treating e.g. colorectal cancer

机译:包含ZD6126以及具有5-氟,CPT-11或5-FU和CPT-11的具有血管破坏活性的组合物,用于治疗例如糖尿病。大肠癌

摘要

A method for the production of a vascular damaging effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation, particularly a method for the treatment of a cancer involving a solid tumour, such as colorectal cancer, which comprises one of: the administration of ZD6126 in combination with 5-FU; the administration of ZD6126 in combination with CPT-11; and the administration of ZD6126 in combination with 5-FU and CPT-11. Also claimed are pharmaceutical compositions and kits comprising one of: ZD6126 and CPT-11; and ZD6126 and 5-FU and CPT-11. Further claimed is use of one of : ZD6126 and 5-FU; ZD6126 and CPT-11; and ZD6126 and 5-FU and CPT-11, in the manufacture of a medicament for use in the production of a vascular damaging effect in a warm-blooded animal which is optionally being treated with ionising radiation.
机译:一种在温血动物例如人中产生血管破坏作用的方法,该方法任选地用电离辐射治疗,特别是用于治疗涉及实体瘤的癌症例如结直肠癌的方法,该方法包括:其中之一:ZD6126与5-FU联合给药; ZD6126与CPT-11联合给药; ZD6126与5-FU和CPT-11的联合给药。还要求保护的药物组合物和试剂盒包含以下之一:ZD6126和CPT-11; ZD6126、5-FU和CPT-11。还要求保护使用以下之一:ZD6126和5-FU; ZD6126和CPT-11;以及ZD6126和5-FU和CPT-11,用于制造在温血动物中产生血管损伤作用的药物,该动物可选地接受电离辐射治疗。

著录项

  • 公开/公告号NO20055888L

    专利类型

  • 公开/公告日2006-03-16

    原文格式PDF

  • 申请/专利权人 ANGIOGENE PHARMACEUTICALS LTD;

    申请/专利号NO20050005888

  • 发明设计人 RYAN ANDERSON JOSEPH;

    申请日2005-12-12

  • 分类号A61K31/505;A61K31/506;A61K31/66;A61P35;

  • 国家 NO

  • 入库时间 2022-08-21 21:38:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号